FDA Warns of Faulty B. Braun Dialysis Tubing Sets
On November 2, 2026, the US Food and Drug Administration issued an early alert regarding a recall of certain B. Braun Medical Inc. Streamline Bloodline Sets used for hemodialysis. On October 20, 2026, B. Braun sent letters asking customers to stop using, quarantine, and return affected units from model SL-2010M2096. A missing solvent step during assembly left dialyzer connectors without proper bonding. This defect can cause bloodline tubing to detach or leak during dialysis, potentially leading to blood loss, circuit blockage, or air entering the blood stream. Significant blood loss or air embolisms can cause severe illness or death. As of October 10, 2026, B. Braun had reported no serious injuries or deaths connected to the issue. Medical staff and distributors must identify affected lots and contact B. Braun for returns.
What was announced
The US Food and Drug Administration issued an early safety alert on November 2, 2026, concerning B. Braun Medical Inc. hemodialysis equipment. The notice applies to the Streamline Bloodline Set for Dialog+, model number SL-2010M2096, specifically lots A2600099, A2600128, and A2600136.
On October 20, 2026, B. Braun sent letters advising customers to locate, quarantine, and return the affected bloodline sets to the manufacturer. Distributors were instructed to forward the warning to their recipients. B. Braun reported that a required solvent application step was omitted during device assembly. This error caused inadequate bonding at the dialyzer connector.
What it means
The incomplete bond can cause the arterial tubing connection to separate or leak while a patient receives hemodialysis or during system priming. If a detachment occurs, blood can escape from the extracorporeal circuit. Staff must then pause treatment and switch out the bloodline set. Blood loss can lead to hospitalization, corrective medical care, or death.
Inadequate bonding can also allow air to enter the blood tubing. Dialysis machine sensors usually detect air in the circuit, but resolving the issue requires staff intervention, additional monitoring, and medical treatment. If air passes the detector, it can cause an air embolism, which can be fatal. As of October 10, 2026, B. Braun had received no reports of serious injuries or deaths related to this assembly defect.
What the announcement does not tell us
The FDA alert does not state the total number of bloodline units affected across the three recalled lots. It does not explain how the solvent step was missed during manufacturing or how the error was discovered. The notice also does not state whether replacement bloodline sets are readily available to clinics or how long B. Braun will take to process returns.
How this was written
This analysis was written with AI from the official announcement below, using only facts that announcement states. The quoted wording is FDA MedWatch Safety Alerts’s own. Always check the original before acting on anything here.
The dialyzer connector may not be attached appropriately, resulting in leaking and potential blood loss.
Opens www.fda.gov
More from FDA MedWatch Safety Alerts
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.